Rhumbline Advisers

Filing Details

13F-HR/A2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-29
Total Holdings
4,182
Total Value
106905259736
Accession Number
0001115418-25-000005
Form Type
13F-HR/A
Manager Name
Rhumbline Advisers
Data Enrichment
81% identified
3,407 identified775 unidentified

Holdings

4,182 positions
Manager:
Search and click to pin securities to the top
Page 173 of 210
Biomea Fusion, Inc.
Shares:
40477(+8.1%)
Value:
$86.2M(-40.6%)
466249208
Shares:
7004(+0.0%)
Value:
$86.0M(-11.8%)
GYRE THERAPEUTICS, INC.
Shares:
11141(+6.8%)
Value:
$86.0M(-31.9%)
46434G830
Shares:
2020(+0.0%)
Value:
$85.5M(+17.6%)
Cabaletta Bio, Inc.
Shares:
61388(-3.2%)
Value:
$85.0M(-40.9%)
Black Diamond Therapeutics, Inc.
Shares:
54836(-2.3%)
Value:
$85.0M(-29.2%)
233806306
Shares:
11894(+0.0%)
Value:
$84.6M(+2.2%)
TWIN DISC INC
Shares:
11171(-3.7%)
Value:
$84.6M(-37.9%)
MAG SILVER CORP
Shares:
5463(-6.9%)
Value:
$83.5M(+4.5%)
GEOSPACE TECHNOLOGIES CORP
Shares:
11559(-12.0%)
Value:
$83.3M(-36.7%)
784375404
Shares:
4093(-1.9%)
Value:
$82.7M(+5.6%)
ENI SPA
Shares:
2659(+0.0%)
Value:
$82.2M(+13.0%)
KINGSWAY FINANCIAL SERVICES INC
Shares:
10327(-14.7%)
Value:
$81.8M(-19.3%)
Upstream Bio, Inc.
Shares:
13327(-20.3%)
Value:
$81.6M(-70.3%)
Stereotaxis, Inc.
Shares:
45997(+6.4%)
Value:
$80.9M(-17.9%)
890880206
Shares:
5944(+0.0%)
Value:
$80.7M(+7.9%)
Corbus Pharmaceuticals Holdings, Inc.
Shares:
15139(+0.2%)
Value:
$80.4M(-54.9%)
BCE INC
Shares:
3496(-6.9%)
Value:
$80.3M(-7.8%)
35804M105
Shares:
7421(+0.0%)
Value:
$80.1M(+23.3%)
SUTRO BIOPHARMA, INC.
Shares:
122816(-3.1%)
Value:
$79.9M(-65.7%)